96952 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans; Cytokines; Lymphokines; Interferons; Chemokines Alpha-chemokines, e.g. NAP-2, ENA-78, GRO-alpha/MGSA/NAP-3, GRO-beta/MIP-2alpha, GRO-gamma/MIP-2beta, IP-10, GCP-2, MIG, PBSF, PF-4, KC
HETERODIMERIC HUMAN IgG1 POLYPEPTIDES WITH ISOELECTRIC POINT MODIFICATIONS
#2CXCL-BPI FUSION PROTEIN AND USE THEREOF
#3HETERODIMERIC HUMAN IgG1 POLYPEPTIDES WITH ISOELECTRIC POINT MODIFICATIONS
#4COMPOSITIONS COMPRISING CXCL10-DERIVED PEPTIDES AND METHODS OF USE THEREOF
#5HETERODIMERIC HUMAN IgG1 POLYPEPTIDES WITH ISOELECTRIC POINT MODIFICATIONS
#6HETERODIMERIC HUMAN IgG1 POLYPEPTIDES WITH ISOELECTRIC POINT MODIFICATIONS
#7CHEMOKINE BIOLOGICS FOR TREATING INFLAMMATION-RELATED DISEASES AND DISORDERS
#8TREATMENT OF THE CORNEAL ENDOTHELIUM
#9REDUCING THE RISK OF MAJOR ADVERSE CARDIAC EVENTS
#10REDUCING THE RISK OF MAJOR ADVERSE CARDIAC EVENTS
#11MULTIVALENT DISPLAY ON ENVELOPED PARTICLES WITH HUMAN OLIGOMERIZATION DOMAINS
#12MUTANT E1A ANTAGONIZING UBIQUITINATION-MEDIATED DEGRADATION AND ITS USE IN THE PREPARATION OF POTENTIATED ONCOLYTIC ADENOVIRUSES AND IMMUNE POTENTIATORS
#13Atomic Description of Immune Complex that Causes Heparin-Induced Thrombocytopenia
#14HETERODIMERIC HUMAN IgG1 POLYPEPTIDES WITH ISOELECTRIC POINT MODIFICATIONS
#15COMPUTER-IMPLEMENTED DESIGN OF PEPTIDE:RECEPTOR SIGNALING COMPLEXES FOR ENHANCED CHEMOTAXIS
#16RNA CONSTRUCT
#17CLEAVABLE ACTIVATORS OF CXCR3 AND METHODS OF USE
#18METHODS FOR REDUCING ELEVATED GLUCOSE LEVELS
#19Atomic description of immune complex that causes heparin-induced thrombocytopenia
#20A CONJUGATE, COMPOSITION AND METHOD FOR NONCOVALENT ANTIBODY CATENATION THAT INCREASES ANTIGEN-BINDING AVIDITY OF AN ANTIBODY IN PROPORTION TO THE DENSITY OF A TARGET ANTIGEN
#21Adenovirus armed with bispecific T cell activator
#22GENETICALLY MODIFIED STEM CELLS
#23A CONJUGATE, COMPOSITION AND METHOD FOR NONCOVALENT ANTIBODY CATENATION THAT INCREASES ANTIGEN-BINDING AVIDITY OF AN ANTIBODY IN PROPORTION TO THE DENSITY OF A TARGET ANTIGEN
#24ENCAPSULATED RNA REPLICONS AND METHODS OF USE
#25PRODUCTS AND METHODS FOR THE DIAGNOSIS AND DIFFERENTIATION OF HEPARIN-INDUCED THROMBOCYTOPENIA FROM VACCINE-INDUCED IMMUNE THROMBOTIC THROMBOCYTOPENIA AND NON-HEPARIN-INDUCED THROMBOCYTOPENIA
#26METHODS AND COMPOSITIONS FOR TREATING CANCER WITH ECM-AFFINITY PEPTIDES LINKED TO IMMUNOTHERAPEUTIC ANTIBODIES
#27LENTIVIRAL VECTORS ENABLING ROUTING ANTIGENS TO MHC-II PATHWAY AND INDUCING CD4+ AND CD8+ T-CELL RESPONSES IN A HOST
#28HUMANIZED ANTIBODIES WITH ULTRALONG COMPLEMENTARY DETERMINING REGIONS
#29A FUSION PROTEON OF STROMAL CELL-DERIVED FACTOR-1 (SDF-1) AND INTERLEUKIN-2 (IL-2) AND APPLICATIONS THEREOF
#30Screening method for effective target - E3 ligase combinations
#31Atomic description of immune complex that causes heparin-induced thrombocytopenia
#32REDUCING THE RISK OF MAJOR ADVERSE CARDIAC EVENTS
#33Methods of prognosis and treatment
#34Genetically modified stem cells
#35THERAPEUTIC NANOCONJUGATES AND USES THEREOF
#36MULTI-FUNCTIONAL FUSION PROTEINS AND USES THEREOF
#37PLASMID CONSTRUCTS FOR TREATING CANCER AND METHODS OF USE
#38Cleavable activators of CXCR3 and methods of use
#39Genetically modified stem cells
#40COMPOSITIONS AND METHODS FOR COMBATING MULTIDRUG-RESISTANT BACTERIA
#41HETERODIMERIC HUMAN IgG1 POLYPEPTIDES WITH ISOELECTRIC POINT MODIFICATIONS
#42Treatment of infection by human enterovirus D68
#43Methods for reducing elevated glucose levels
#44Using nucleic acids encoding NAP-2 polypeptides to improve cardiac function
#45Genetically modified stem cells
#46Humanized antibodies with ultralong complementary determining regions
#47Adenovirus armed with bispecific T cell activator
#48Oncolytic viral delivery of therapeutic polypeptides
#49Methods of treating cancer with placenta growth factor peptide linked to immunotherapeutic antibodies
#50TREATMENT OF INFECTION BY HUMAN ENTEROVIRUS D68
#51Atomic description of immune complex that causes heparin-induced thrombocytopenia
#52METHODS AND COMPOSITIONS FOR CANCER THERAPY
#53Methods of prognosis and treatment
#54CHEMOKINE-CYTOKINE FUSION PROTEINS AND THEIR APPLICATIONS
#55Treating diabetes with genetically modified beta cells
#56Generating targeted sequence diversity in fusion proteins
#57SUPPRESSION OF CANCER
#58Trapped Chemokine Variants as Therapeutic Agents for Inflammation-Related Diseases Including Infections, Diabetes, and Cancer
#59Oncolytic viral delivery of therapeutic polypeptides
#60SDF-1 FOR ANAL AND SPHINCTER WOUND HEALING
#61Three-dimensional tissue scaffold with stem cell attracting element and use thereof
#62NAP-2 polypeptides and methods for modulating immune system activity in heart tissue
#63METHODS OF MESENCHYMAL STEM CELL MOBILIZATION AND EXPANSION
#64Generating targeted sequence diversity in fusion proteins
#65Atomic description of immune complex that causes heparin-induced thrombocytopenia
#66Class of therapeutic protein based molecules
#67Chemokine-cytokine fusion proteins of SDF-1 and CD40L
#68Treatment of infection by human enterovirus D68
#69METHODS FOR IDENTIFYING PATIENTS RESPONSIVE TO ANTI-PD-L1 ANTIBODY THERAPY
#70Method for inducing ectodermal differentiation of embryoid bodies derived from human pluripotent stem cells by CXCR2 stimulation
#71Protease-resistant mutants of stromal cell derived factor-1 in the repair of tissue damage
#72IDENTIFICATION OF CXCR8, A NOVEL CHEMOKINE RECEPTOR
#73Surface-binding peptide
#74Peptide for promoting osteogenic differentiation or vascularization and use thereof
#75ENGINEERED CXCL12 ALPHA LOCKED DIMER POLYPEPTIDE
#76Using nucleic acids encoding NAP-2 and TGF-alpha polypeptides to improve cardiac function
#77Class of therapeutic protein based molecules
#78Humanized antibodies with ultralong complementary determining regions
#79Epitope of IP-10 and antibody to same
#80Generating targeted sequence diversity in fusion proteins
#81IP-10 antibodies and their uses
#82Suppression of cancer
#83Methods for repairing tissue damage using protease-resistant mutants of stromal cell derived factor-1
#84Compositions and Methods for Inhibiting CCL3
#85Engineered CXCL12 alpha locked dimer polypeptide
#86Efficient sterilization of fish by disruption of germ cell development
#87Heterodimeric human IgG1 polypeptides with isoelectric point modifications
#88Chemokine derived peptides that bind with chemokine receptor CXCR3 and uses for chronic wound and angiogenesis inhibition treatments
#89Use of SDF-1 to mitigate scar formation
#90IP-10 antibodies and their uses
#91Mutants PF4 polypeptides exhibiting an increased anti-angiogenic activity
#92THERAPEUTIC METHOD FOR INCREASING PANCREATIC BETA CELL MASS
#93Chemokine-Chaperone Fusion Proteins
#94SUPPRESSION OF CANCER
#95PURGING OF AN EX VIVO HEMATOPOIETIC STEM CELL CULTURE OF CANCER CELLS
#96Protease-resistant mutants of stromal cell derived factor-1 in the repair of tissue damage
#97Class of therapeutic protein based molecules
#98TREATMENT OF LIQUID CANCERS
#99Engineered CXCL12 alpha locked dimer polypeptide
#100CXCL12 GAMMA A CHEMOKINE AND USES THEREOF
#101Antibodies to stromal cell-derived factor-1 polypeptides
#102METHODS OF USING ISOLATED RECOMBINANT POLYPEPTIDE ANTAGONISTS OF SDF-1
#103Single branch heparin-binding growth factor analogs
#104SDF-I-BASED GLYCOSAMINOGLYCAN ANTAGONISTS AND METHODS OF USING SAME
#105Methods of screening for compounds that modulate the activity of ADEC, a chemokine expressed in inflamed adenoid
#106COMPOSITIONS AND METHODS OF PROMOTING WOUND HEALING
#107Method for efficient production of monocyte-derived multipotent cell (MOMC)
#108Method of suppressing disease severity of multiple sclerosis using chemokine CXC11
#109IP-10 antibodies and their uses
#110MAMMALIAN CHEMOKINES; RECEPTORS; REAGENTS; USES
#111Stromal cell-derived factor-1 polypeptides, polynucleotides, modulators thereof and methods of use
#112Methods for promoting protection and regeneration of bone marrow using CXCL9 and anti-CXCL9 antibodies
#113Engineered CXCL12 α locked dimer polypeptide
#114Method of treatment using high-affinity antagonists of ELR-CXC chemokines
#115CXCR4 ANTAGONIST TREATMENT OF HEMATOPOIETIC CELLS
#116LENTIVIRAL VECTOR-MEDIATED GENE TRANSFER AND USES THEREOF
#117Chimeric polypeptides containing chemokine domains
#118Leukocyte Adhesion Inhibitor-1 (LAI-1)
#119METHOD AND COMPOSITION FOR INCREASING THE ENGRAFTMENT EFFICIENCY OF STEM CELLS
#120Novel Inhibitors of Angiogenesis
#121Stromal cell-derived factor-1 polypeptides, polynucleotides, modulators thereof and methods of use
#122Nucleic acid molecule comprising a nucleic acid sequence coding for a chemokine, a neuropeptide precursor, or at least one neuropeptide
#123DNA ENCODING FOR RECOMBINANT POLYPEPTIDE EMUTANTS OF HUMAN STROMAL CELL-DERIVED FACTOR 1
#124Antibodies to Chemokine Alpha-5
#125Pf4 Pharmacophores and Their Uses
#126Synthetic approach to designed chemical structures
#127Single branch heparin-binding growth factor analogs
#128Binding peptidomimetics and uses of the same
#129MIGRATION OF HEMATOPOIETIC STEM CELLS AND PROGENITOR CELLS TO THE LIVER
#130Methods of treatment with anitbodies to a chemokine expressed in inflamed adenoid
#131MAMMALIAN CHEMOKINES; RECEPTORS; REAGENTS; USES
#132Synthetic chemokine receptor ligands and methods of use thereof
#133Design of CXC chemokine analogs for the treatment of human diseases
#134Chimeric polypeptides containing chemokine domains
#135NAP derivatives
#136Interferon-inducible protein-10 (IP-10 or CXCL10) chemokine analogs for the treatment of human diseases
#137Delivery vehicle for recombinant proteins
#138Chemokine conjugates
#139DNAXCCR10
#140Migration of hematopoietic stem cells and progenitor cells to the liver
#141Embryo implantation inhibitor
#142Antagonists of cxcr3-binding cxc chemokines
#143Synthetic approach to designed chemical structures
#144Compounds and methods to inhibit or augment an inflammatory response
#145Lentiviral vector-mediated gene transfer and uses thereof
#146Polynucleotides encoding leukocyte adhesion inhibitor-1 (LAI-1)
#147CXCR4 antagonist treatment of hematopoietic cells
#148Antibodies to Chemokine Alpha-5
#149Antibodies to chemokine Alpha-6
#150IP-10 antibodies and their uses
#151Migration of hematopoietic stem cells and progenitor cells to the liver
#152Prophylactic and therapeutic benefits of a new class of immune stimulating peptides
#153Method for treating cancer by vector-mediated delivery of one or more anti-angiogenic or pro-apoptotic genes
#154Chemokines with amino-terminal modifications
#155Methods of making chemokine alpha 3 antibodies